Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

"Who has to do it at the end of the day? Programme officials or hospital authorities?" Airborne infection control at drug resistant tuberculosis (DR-TB) centres of Karnataka, India: a mixed-methods study.

Akshaya KM, Shewade HD, Aslesh OP, Nagaraja SB, Nirgude AS, Singarajipura A, Jacob AG.

Antimicrob Resist Infect Control. 2017 Nov 6;6:111. doi: 10.1186/s13756-017-0270-4. eCollection 2017.

2.

Enhancing the role of private practitioners in tuberculosis prevention and care activities in India.

Anand T, Babu R, Jacob AG, Sagili K, Chadha SS.

Lung India. 2017 Nov-Dec;34(6):538-544. doi: 10.4103/0970-2113.217577. Review.

3.

A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.

Comiskey DF Jr, Jacob AG, Sanford BL, Montes M, Goodwin AK, Steiner H, Matsa E, Tapia-Santos AS, Bebee TW, Grieves J, La Perle K, Boyaka P, Chandler DS.

Oncogene. 2018 Jan 4;37(1):95-106. doi: 10.1038/onc.2017.282. Epub 2017 Sep 11.

4.

Intron retention as a component of regulated gene expression programs.

Jacob AG, Smith CWJ.

Hum Genet. 2017 Sep;136(9):1043-1057. doi: 10.1007/s00439-017-1791-x. Epub 2017 Apr 8. Review.

5.

Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.

Kumar A, Casulo C, Yahalom J, Schöder H, Barr PM, Caron P, Chiu A, Constine LS, Drullinsky P, Friedberg JW, Gerecitano JF, Hamilton A, Hamlin PA, Horwitz SM, Jacob AG, Matasar MJ, McArthur GN, McCall SJ, Moskowitz AJ, Noy A, Palomba ML, Portlock CS, Straus DJ, VanderEls N, Verwys SL, Yang J, Younes A, Zelenetz AD, Zhang Z, Moskowitz CH.

Blood. 2016 Sep 15;128(11):1458-64. doi: 10.1182/blood-2016-03-703470. Epub 2016 Jul 25.

6.

Intensified tuberculosis case finding amongst vulnerable communities in southern India.

Reddy KK, Ananthakrishnan R, Jacob AG, Das M, Isaakidis P, Kumar AM.

Public Health Action. 2015 Dec 21;5(4):246-8. doi: 10.5588/pha.15.0048.

7.

Lean diabetes mellitus: An emerging entity in the era of obesity.

George AM, Jacob AG, Fogelfeld L.

World J Diabetes. 2015 May 15;6(4):613-20. doi: 10.4239/wjd.v6.i4.613. Review.

8.

TB Treatment Delays in Odisha, India: Is It Expected Even after These Many Years of RNTCP Implementation?

Ilangovan K, Nagaraja SB, Ananthakrishnan R, Jacob AG, Tripathy JP, Tamang D.

PLoS One. 2015 Apr 30;10(4):e0125465. doi: 10.1371/journal.pone.0125465. eCollection 2015.

9.

Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.

Comiskey DF Jr, Jacob AG, Singh RK, Tapia-Santos AS, Chandler DS.

Nucleic Acids Res. 2015 Apr 30;43(8):4202-18. doi: 10.1093/nar/gkv223. Epub 2015 Apr 6.

10.

Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways.

Jacob AG, Singh RK, Comiskey DF Jr, Rouhier MF, Mohammad F, Bebee TW, Chandler DS.

PLoS One. 2014 Aug 8;9(8):e104444. doi: 10.1371/journal.pone.0104444. eCollection 2014.

11.

The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.

Jacob AG, Singh RK, Mohammad F, Bebee TW, Chandler DS.

J Biol Chem. 2014 Jun 20;289(25):17350-64. doi: 10.1074/jbc.M114.554717. Epub 2014 May 5.

12.

Sleeping with the enemy: the United Nations Development Programme and its position on the non-communicable disease epidemic.

Jacob AG, Lal PG, Buragohain A.

Trop Med Int Health. 2014 Feb;19(2):136-9. doi: 10.1111/tmi.12236. Epub 2014 Jan 2.

13.

Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.

Jacob AG, O'Brien D, Singh RK, Comiskey DF Jr, Littleton RM, Mohammad F, Gladman JT, Widmann MC, Jeyaraj SC, Bolinger C, Anderson JR, Barkauskas DA, Boris-Lawrie K, Chandler DS.

Neoplasia. 2013 Sep;15(9):1049-63.

14.

Macrophage activation syndrome following Acinetobacter baumannii sepsis.

John TM, Jacob CN, Ittycheria CC, George AM, Jacob AG, Subramaniyam S, Puthiyaveettil J, Jayaprakash R.

Int J Infect Dis. 2012 Mar;16(3):e223-4. doi: 10.1016/j.ijid.2011.12.002. Epub 2012 Jan 27.

15.

Advances in pediatric rhabdomyosarcoma characterization and disease model development.

O'Brien D, Jacob AG, Qualman SJ, Chandler DS.

Histol Histopathol. 2012 Jan;27(1):13-22. doi: 10.14670/HH-27.13. Review.

16.

Klippel-Trénaunay syndrome: spectrum and management.

Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P.

Mayo Clin Proc. 1998 Jan;73(1):28-36.

PMID:
9443675

Supplemental Content

Loading ...
Support Center